Compare SHC & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHC | MAIN |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.8B |
| IPO Year | 2020 | 2014 |
| Metric | SHC | MAIN |
|---|---|---|
| Price | $18.47 | $53.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $20.33 | ★ $61.57 |
| AVG Volume (30 Days) | ★ 2.6M | 671.9K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 8.04% |
| EPS Growth | ★ 68.75 | N/A |
| EPS | 0.09 | ★ 0.93 |
| Revenue | ★ $1,163,617,000.00 | N/A |
| Revenue This Year | $7.51 | $6.27 |
| Revenue Next Year | $6.00 | $5.14 |
| P/E Ratio | $204.33 | ★ $55.49 |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $10.94 | $48.95 |
| 52 Week High | $19.85 | $67.77 |
| Indicator | SHC | MAIN |
|---|---|---|
| Relative Strength Index (RSI) | 70.29 | 59.34 |
| Support Level | $15.13 | $52.25 |
| Resistance Level | $19.85 | $58.36 |
| Average True Range (ATR) | 0.46 | 1.02 |
| MACD | 0.12 | 0.21 |
| Stochastic Oscillator | 96.77 | 91.37 |
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Main Street Capital Corp is a principal investment firm focused on providing customized long-term debt and equity capital solutions to lower middle market ("LMM") companies and debt capital to private ("Private Loan") companies owned by or in the process of being acquired by a private equity fund. The group invests principally in secured debt investments, equity investments, warrants, and other securities of LMM companies, typically based in the U.S. The company operates as a single segment with a principal investment objective to maximize total return by generating current income from debt investments and current income and capital appreciation from equity and equity-related investments.